Log in  First Connection?

Acute & Chronic Kidney InjuryArchives

A comparative analysis of drug-induced kidney injury adverse reactions between cyclosporine and tacrolimus based on the FAERS database

 Published on 07/05/2025 |  Original article (Full-text)  | Xu Min et al. | BMC Immunology 2025; 26(1): 35

Nephrotoxicity is the inability of the kidneys to properly detoxify and excrete drugs and toxic chemicals due to destruction or injury caused by endogenous or exogenous toxicants [1]. It is characterized by elevated serum creatinine and urea, decreased GFR (glomerular filtration) rate, and may be accompanied...

The predictive value of renal vascular resistance index and serum biomarkers for sepsis-associated acute kidney injury: a retrospective study

 Published on 30/04/2025 |  Original article (Full-text)  | Huang Daofeng et al. | BMC Nephrology 2025; 26(1): 208

Sepsis, a critical and often deadly condition arising from an abnormal defensive response to infection, represents a substantial load on healthcare systems globally [1, 2–3]. It is a primary cause of morbidity and fatalities, with an approximate annual incidence of approximately 31.5 million...

Does combining urine sediment examination to renal cell arrest and damage biomarkers improve prediction of progression and mortality of sepsis associated acute kidney injury?

 Published on 23/04/2025 |  Original article (Full-text)  | Elsayed Mohamed Mamdouh et al. | BMC Nephrology 2025; 26(1): 195

Acute kidney injury (AKI) is a frequent medical condition among hospitalized patients. AKI occurs in 31 to 65% of patients with septic shock and is linked to higher mortality and consumption of health care resources [1, 2]. A definition for sepsis-associated AKI (SA-AKI) was developed by the Acute Disease...

The association between pan-immune-inflammation value with mortality in critically ill patients with sepsis-associated acute kidney injury

 Published on 16/04/2025 |  Original article (Full-text)  | Zhou Yidan et al. | BMC Infectious Diseases 2025; 25(1): 486

Acute kidney injury (AKI) and sepsis are common disease, imposing a significant economic burden on healthcare, with direct medical costs of approximately $10 billion and $20 billion annually, respectively [1, 2]. It is notable that the combination of AKI and sepsis frequently occurs in the...

Risk analysis and mediation analysis of stress hyperglycemia ratio and all-cause mortality in patients with acute kidney injury

 Published on 09/04/2025 |  Original article (Full-text)  | Shi Yue et al. | Diabetology & Metabolic Syndrome 2025; 17(1): 112

Acute kidney injury (AKI) represents a major global public health challenge, affecting millions of patients worldwide and characterized by a rapid deterioration of renal function over a short period of time [1]. Approximately 10–15% of hospitalized patients experience AKI, with the incidence reaching...